Keith Fandrick
Vermögen: - $ am 30.09.2026
Vermögen: - $ am 30.09.2026
Dr. Keith R.
Fandrick is a Chief Operating Officer at IRulya Therapeutics, Inc. Dr. Fandrick was previously employed as a Chief Operating Officer by OrphAI Therapeutics, Inc. He received his undergraduate degree from the University of California, a graduate degree from Harvard University, an MBA from Kenan-Flagler Business School and a doctorate degree from Harvard University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 08.10.2026 | 0 ( -.--% ) | - $ | 30.09.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| IRULYA THERAPEUTICS INC. | Geschäftsführer | 08.10.2026 |
| Unternehmen | Position | Ende |
|---|---|---|
AI Therapeutics, Inc.
AI Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on developing therapies for pulmonary diseases | Geschäftsführer | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kenan-Flagler Business School
Kenan-Flagler Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California
University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quince Therapeutics, Inc.
Quince Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of central nervous system disorders and Alzheimer’s diseases | Health Technology |
AI Therapeutics, Inc.
AI Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on developing therapies for pulmonary diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen